UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from _________ to _________ Commission file number: 001-39785 LIFEMD, INC. (Exact name of registrant as specified in its charter) Delaware 76-0238453 (State or other Jurisdic ...

Key Points LifeMD is a telehealth platform riding the GLP-1 trend to double-digit revenue growth, with its subscription weight management business driving projected EBITDA growth of 67% in 2024. LifeMD reported Q4 2023 EPS of 15 cents, doubling consensus analyst estimates for a loss of 14 cents, while revenues rose 60% YoY to $44.86 million, beating $40.48 million estimates. LifeMD telehealth subscribers rose 27% YoY to 215, 000 and weight management subscribers exceeded 22,000, up 100% sequentially. 5 stoc ...

LifeMD, Inc. (NASDAQ:LFMD) Q4 2023 Earnings Conference Call March 11, 2024 4:30 PM ET Company Participants Justin Schreiber - Chairman and CEO Marc Benathen - CFO Conference Call Participants David Larsen - BTIG William Wood - B. Riley Alex Fuhrman - Craig-Hallum Ilya Zubkov - Freedom Broker Yi Chen - H.C. Wainwright Operator Good afternoon. Thank you for joining us today to discuss LifeMD's Results for the Fourth Quarter and Year Ended December 31, 2023. Joining on the call today are Justin Schreiber, Chai ...

LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to earnings of $0.02 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 14.29%. A quarter ago, it was expected that this company would post a loss of $0.18 per share when it actually produced a loss of $0.20, delivering a surprise of -11.11%.Over the last four quarters, the company has surpas ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________________ to __________________________ Commission file number 001-39785 LIFEMD, INC. (Exact name of registrant as specified in its charter) Delaw ...

NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care, today announced that management will be participating in three upcoming investor conferences and a webinar discussing GLP-1s. D.A. Davidson GLP-1 Webinar, February 26, 2024. Justin Schreiber, Chief Executive Officer of LifeMD, will participate in a webinar with equity research analysts Gil Luria and Linda Bolton Weiser to discuss his perspective on GLP-1s.TD Cowen's 44th Annual Health Care Con ...

NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care, today announced its participation in the Maxim Group 2024 Healthcare IT Virtual Conference, being held January 24-25, 2024. Management will participate in a virtual fireside chat on Wednesday, January 24th at 10:00 a.m. Eastern time and will also hold one-on-one meetings throughout the conference. Investors can register for the conference here. About LifeMD, Inc.LifeMD is a leading provider of ...

NEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc.™ (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ:LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on January 15, 2024, to holders of record at the close of business on January 5, 2024. About LifeMD, Inc. LifeMD is a leading provider of virtual pr ...

LifeMD, Inc. (NASDAQ:LFMD) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Justin Schreiber - Chairman & Chief Executive Officer Marc Benathen - Chief Financial Officer Conference Call Participants Sarah James - Cantor Fitzgerald Yi Chen - H.C. Wainwright Brandon Carney - B. Riley Operator Good afternoon. Thank you for joining us today to discuss the results for LifeMD's Third Quarter Ended September 30, 2023. Joining the call today are Justin Schreiber, Chairman and Chief ...

Rapid growth in profitability after achieving adjusted EBITDA profit in Q4 '22 Annual consolidated adjusted EBITDA ($ millions) $10-$11M 2022A $(15)M ($38)M 2023E 2021A Note: Consolidated adjusted EBITDA includes Telehealth and WorkSimpli results. 16 Rapidly expanding gross margins and increasing leverage on marketing spend driving continued growth in profitability 82% 83% 84% 85% 86% 87% 88% 89% 90% Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 20223 Q3 2023 Net Revenue ($ Millions) 72% 55% 62% 50% 54% 51% 0% 25% 50% ...